13F Holdings
中文EN

NPLY Naploy Corp.

Services-Health Services · OTC · SEC CIK 1978111 · Fiscal year ends 07/31

Financial factors as of 2026-07-31 (2026Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY127.6%
TTM net income YoY-52.9%
TTM EPS YoY0.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-175.0%
Net margin-175.0%
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-54.1%
ROIC (approx.)—
Asset turnover0.31x

Leverage & solvency

Liabilities / assets174.0%
Debt / equity—
Current ratio0.40x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.43x
Accruals ratio-30.8%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-07-31FY20252025-07-31FY20242024-07-31
Income statement
Revenue$18,097$7,950$0
SG&A expense$21,064$88$273
Operating income-$31,676-$20,714-$20,301
Income tax$0$0$0
Net income-$31,676-$20,714-$20,301
EBITDA——-$11,301
EPS (basic)-0.01-0.01-0.01
EPS (diluted)-0.01-0.01-0.01
Weighted avg. shares (diluted)3.80M3.80M2.32M
Balance sheet
Cash & equivalents$20,228$12,717$32,345
Current assets$40,228$32,717$32,345
Intangibles$17,625$26,625$35,625
Total assets$57,853$59,342$67,970
Current liabilities$100,657$70,470$59,759
Total liabilities$100,657$70,470$59,759
Shareholders' equity-$42,804-$11,128$8,211
Shares outstanding3.80M3.80M3.73M
Cash flow statement
Operating cash flow-$13,651-$21,165-$17,001
Investing cash flow—$0-$20,000
Financing cash flow$21,162$1,537$68,451
Depreciation & amortization——$9,000

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.